Giant Cell Arteritis: State of the Art in Diagnosis, Monitoring, and Treatment

Abid Awisat1, Shiri Keret1, Amal Silawy2

  • 1Rheumatology Unit, Bnai Zion Medical Center, Haifa, Israel.

Insights

Giant cell arteritis (GCA) diagnosis and treatment have significantly advanced. Novel therapies and improved diagnostic tools now offer better management for this common form of vasculitis.

Area of Science:

  • Rheumatology
  • Immunology
  • Internal Medicine

Background:

  • Giant cell arteritis (GCA) is the most common vasculitis affecting adults.
  • Recent advancements have significantly improved GCA management.
  • Large-vessel vasculitis requires effective diagnostic and therapeutic strategies.

Purpose of the Study:

  • To review current state-of-the-art diagnostic approaches for GCA.
  • To discuss modern monitoring techniques for large-vessel vasculitis.
  • To outline novel and effective treatment options for GCA.

Main Methods:

  • Review of recent literature on GCA diagnosis and treatment.
  • Analysis of advancements in imaging modalities for vasculitis.
  • Evaluation of novel biological therapies for GCA.

Main Results:

  • Highly sensitive diagnostic tools enhance GCA detection.
  • Modern imaging aids in diagnosis and monitoring of large-vessel vasculitis.
  • Novel biological therapies have revolutionized GCA treatment.

Conclusions:

  • Current diagnostic tools and imaging offer improved GCA management.
  • Novel biological therapies represent a significant breakthrough in treating GCA.
  • Comprehensive review highlights the evolving landscape of GCA care.

Related Concept Videos

Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
13
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
16
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
29
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
19
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
29
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
23